ADH5 and cancer: Indeed, GSNOR, the enzyme devoted to removing S-nitrosylation from proteins, is known to be downregulated in several cancer types [6, 8, 57], suggesting that S-nitrosylation and its structural consequences could be enhanced in a cancer setting.